Open AccessOnce-a-week tigecycline for the treatment of drug-resistant TB
Author(s) -
Devyani Deshpande,
Gesham Magombedze,
Shashikant Srivastava,
Paula Bendet,
Pooi S Lee,
Kayle Cirrincione,
Katherine R. Martin,
Keertan Dheda,
Tawanda Gumbo
Publication year - 2019
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkz061
Subject(s) - tigecycline , medicine , rifampicin , pyrazinamide , ethambutol , pharmacodynamics , pharmacology , population , tuberculosis , minocycline , nonmem , pharmacokinetics , microbiology and biotechnology , antibiotics , biology , environmental health , pathology
MDR-TB and XDR-TB have poor outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom